Innovative Product Portfolio electroCore’s flagship products like Truvaga Plus and gammaCore(R) exemplify advanced neuromodulation and wellness solutions that have received industry recognition, making them attractive offerings for healthcare providers seeking cutting-edge non-invasive treatments.

Expanding Market Reach Recent merger with NeuroMetrix and active participation in major industry conferences highlight electroCore’s strategic efforts to broaden its market presence and identify new B2B sales channels in the non-invasive health and wellness sector.

Recognition & Awards The company’s products have garnered multiple awards from reputable magazines, showcasing innovation and efficacy that can be leveraged in marketing pitches to attract health institutions and clinicians interested in proven, award-winning solutions.

Growing Revenue & Funding With revenues in the $10M to $25M range and significant investment of over $100M, electroCore demonstrates strong financial backing and growth potential, creating opportunities to partner with healthcare networks and clinics expanding their neuromodulation offerings.

Focus on Chronic & Brain Conditions electroCore’s emphasis on treating chronic pain, fibromyalgia, and concussion-related symptoms positions its solutions well for institutions specializing in pain management, neurology, and brain injury treatment, opening avenues for targeted sales initiatives.